ARE
Real EstateAlexandria Real Estate Equities
Price Chart
Market Data
Financials
XBRL · SEC EDGAR2016–2025(10yr)| Metric | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025Latest | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $921.7M | $1.1B | $1.3B | $1.5B | $1.9B | $2.1B | $2.6B | $2.9B | $3.1B | $3.0B | -2.9% |
| Net Income | -$65.9M | $169.1M | $379.3M | $363.2M | $771.0M | $571.2M | $521.7M | $103.6M | $322.9M | -$1.4B | -542.7% |
| FFO | $247.5M | $585.9M | $857.0M | $907.8M | $1.5B | $1.4B | $1.5B | $1.2B | $1.5B | -$79.1M | -105.2% |
| FFO Margin | 26.9% | 51.9% | 64.6% | 59.3% | 77.9% | 65.9% | 58.9% | 41.5% | 48.9% | -2.6% | -51.6pp |
| Net Margin | -7.1% | 15.0% | 28.6% | 23.7% | 40.9% | 27.0% | 20.1% | 3.6% | 10.4% | -47.2% | -57.6pp |
| EPS (Diluted) | $-1.99 | $1.58 | $3.52 | $3.12 | $6.01 | $3.82 | $3.18 | $0.54 | $1.80 | $-8.44 | -568.9% |
1. THE BIG PICTURE
Alexandria is currently a business in retreat, executing a massive $1.8 billion disposition program to shore up a balance sheet pressured by high interest rates and a contraction in life science demand. While it remains the "preeminent" pioneer of the laboratory real estate niche, a staggering $1.08 billion net loss in the most recent quarter suggests that its specialized "Megacampus" strategy is currently a source of concentration risk rather than a defensive moat.
2. WHERE THE RISKS HIT HARDEST
The "Megacampus" strategy—designed to drive tenant retention through curated amenities—is directly threatened by the life science industry’s financial distress. If major tenants face bankruptcy or reduced R&DR&DResearch & Development — spending on creating new products or technologies budgets, Alexandria’s specialized laboratory infrastructure becomes a liability; these assets are expensive to maintain, and Alexandria Real Estate Equities notes that competitors with "greater financial resources" may offer aggressive rent concessions to lure away remaining tenants (10-K Item 1). Furthermore, Alexandria’s "disciplined" development pipeline is highly sensitive to interest rate volatility. Rising rates not only increase the cost of its variable-rate debt but also push up capitalization rates, which threatens the valuations of the very properties Alexandria is trying to sell to raise capital (8-K).
3. WHAT THE NUMBERS SAY TOGETHER
The financial data reveals a company trading growth for survival. Alexandria reported a 2.9% decline in revenue—the worst performance in its peer group—while simultaneously slashing general and administrative expenses by 34% to protect its cash flow (8-K). While its gross margin of 69.4% is the highest among its peers, its net margin of -5.9% highlights the severe impact of recent property impairments and a $13.0 billion debt load (XBRL). The market’s lack of confidence is visible in the 6.5% short interest, suggesting that many investors view the 8.0% dividend yield as a compensation for risk rather than a sign of strength (Yahoo Finance).
4. IS IT WORTH IT AT THIS PRICE?
At 7.8x P/FFO, Alexandria trades at a massive 56% discount to the peer median of 17.7x. This "attractively valued" status is only justified if one believes Alexandria Real Estate Equities can exceed the 0.5% long-term growth rate currently priced in by the market (CAPM analysis). While a return to 2.5% GDP-pace growth would justify a much higher 10.8x multiple, Alexandria Real Estate Equities’s current trajectory is moving in the opposite direction. Alexandria is the only peer in its set with negative revenue growth, trailing far behind competitors like Ventas (+18.5%). Investors are effectively betting that the $1.8 billion in asset sales will be enough to stabilize the business before a broader downturn in life science funding further erodes occupancy.
5. WHAT WOULD CHANGE THIS VIEW?
- Constructive if Alexandria Real Estate Equities completes its non-core disposition plan with significant gains that lead to a measurable reduction in its $13.0 billion net debt.
- Cautious if the "new competitive supply" management cited begins to force a decline in rental rates or if occupancy levels at the core Megacampuses drop below historical averages.
6. BOTTOM LINE
Structural Advantage: Long-standing industry relationships and a dominant portfolio of specialized Class A laboratory infrastructure in high-barrier innovation clusters.
Bottom Line: Alexandria is a high-yield turnaround play that will remain under pressure until it proves it can de-leverage its balance sheet without sacrificing its core "Megacampus" earnings power.
1. Top 5 Material Risks
- Tenant Financial Distress and Bankruptcy: Alexandria Real Estate Equities relies on rental payments and expense reimbursements for its primary revenue. If significant tenants face financial distress or bankruptcy, Alexandria Real Estate Equities may be unable to collect rent, and bankruptcy courts may authorize the rejection of leases, limiting claims for uncollectible future rent.
- Life Science Industry Dependency: Alexandria Real Estate Equities’s business strategy focuses on the life science industry. Changes in this sector, including reduced research and development budgets, mergers, or the inability of tenants to obtain funding, directly impact the demand for laboratory space and the ability of tenants to pay rent.
- Interest Rate Volatility: Elevated interest rates increase financing costs for Alexandria Real Estate Equities, particularly regarding variable-rate debt under its unsecured senior line of credit and commercial paper program. Higher rates also tend to increase capitalization rates, which can lead to decreased valuations of Alexandria Real Estate Equities’s real estate portfolio.
- Development and Redevelopment Execution: Alexandria Real Estate Equities faces significant risks in its construction projects, including the inability to complete projects on schedule or within budget, unavailability of labor and materials, and the risk that pre-leased tenants may terminate their leases prior to delivery.
- Capital Access and Liquidity: Alexandria Real Estate Equities requires access to debt and equity capital to fund acquisitions and developments. Adverse changes in credit ratings, market illiquidity, or the inability to refinance maturing debt could prevent Alexandria Real Estate Equities from executing its business objectives.
2. Company-Specific Risks
- Geographic Concentration: Alexandria Real Estate Equities’s portfolio is concentrated in specific markets, including Greater Boston, the San Francisco Bay Area, San Diego, and Seattle, making it highly sensitive to local economic, tax, and regulatory conditions in these regions.
- Specialized Infrastructure Costs: Properties owned by Alexandria Real Estate Equities require specialized infrastructure, such as heavy-duty HVAC systems and reinforced concrete floors, which are significantly more costly to maintain and renovate than traditional office space.
- Venture Investment Portfolio: Alexandria Real Estate Equities holds a non-real estate venture investment portfolio in life science companies, which exposes it to speculative risks inherent in venture capital, including potential impairment of asset values and earnings volatility.
- Joint Venture Exposure: As of December 31, 2025, Alexandria Real Estate Equities has $3.63 billion in noncontrolling interests in consolidated real estate joint ventures, where partners may hold rights to force sales or initiate buy/sell processes that could strain liquidity or force the sale of assets.
3. Regulatory/Legal Risks
- REIT Qualification: Failure to qualify as a Real Estate Investment Trust (REIT) would subject Alexandria Real Estate Equities to federal and state income taxes at corporate rates and eliminate the deduction for distributions to stockholders.
- Drug Pricing and Healthcare Policy: Alexandria Real Estate Equities’s tenants are subject to government price controls and healthcare cost-containment measures, such as the "Most-Favored-Nation" executive order, which can reduce tenant profitability and their ability to pay rent.
- NIH Funding and Policy Changes: Alexandria Real Estate Equities is exposed to risks from NIH budget fluctuations and policy changes, such as the 15% cap on indirect cost reimbursements (which was subject to a permanent injunction) and potential future funding restrictions that impact the ability of research institutions to lease space.
- Environmental Liability: Alexandria Real Estate Equities could be held liable for environmental damages resulting from tenants’ use of hazardous materials or from defects such as harmful mold or poor air quality in its properties.
4. Financial Impact Map
Tenant Bankruptcy/Default → Rental Revenue → Alexandria Real Estate Equities’s primary revenue source is derived from rental payments; shortfalls directly impact cash flows and the ability to make distributions. Life Science Industry Downturn → Rental Revenue / Venture Investment Value → Reduced R&DR&DResearch & Development — spending on creating new products or technologies spending by tenants impacts lease renewals and the valuation of Alexandria Real Estate Equities’s non-real estate equity investments. Interest Rate Increases → Interest Expense → Elevated rates increase costs on variable-rate borrowings under the unsecured senior line of credit and commercial paper program. Development Cost Overruns → Net Investments in Real Estate → Higher construction costs for raw materials and labor can reduce expected yields on development and redevelopment projects. REIT Qualification Failure → Net Income / Tax Provision → Loss of REIT status would subject Alexandria Real Estate Equities to federal and state income taxes at regular corporate rates, reducing funds available for distribution.
Recent Filings
| Form | Filed | Period |
|---|---|---|
| 10-K | Jan 2026 | Dec 2025 |
| 8-K | Jan 2026 | — |
| 10-Q | Oct 2025 | Sep 2025 |
| 14A | Apr 2025 | — |
AI-extracted key facts from press releases and SEC filings. Significance 1–10.
Aecon prices secondary offering of 3.82M shares at $39.25 to raise $150M
- ▸Offering of 3,822,000 common shares priced at $39.25 per share
- ▸Gross proceeds of approximately $150,013,500 from treasury shares
- ▸Over-allotment option for additional 573,300 shares worth $22.5 million
- ▸Net proceeds to be used for revolving credit facility repayment
- ▸Underwriters led by CIBC Capital Markets and TD Securities
Alexandria Real Estate Prices $750M Senior Notes Offering Due 2036
- ▸Priced $750M senior notes offering due 2036 at 5.291% yield
- ▸Proceeds earmarked for repayment of existing debt from prior tender offer
- ▸Shares trading 52.3% below 52-week high of $101.21
- ▸Stock remains below 200-day moving average for over one year
- ▸Consensus analyst rating of Hold with $59.64 mean price target